These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19480466)

  • 21. LAAM maintenance vs methadone maintenance for heroin dependence.
    Clark N; Lintzeris N; Gijsbers A; Whelan G; Dunlop A; Ritter A; Ling W
    Cochrane Database Syst Rev; 2002; (2):CD002210. PubMed ID: 12076441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United kingdom.
    Metrebian N; Mott J; Carnwath Z; Carnwath T; Stimson GV; Sell L
    Eur Addict Res; 2007; 13(3):144-7. PubMed ID: 17570910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innovations in agonist maintenance treatment of opioid-dependent patients.
    Haasen C; van den Brink W
    Curr Opin Psychiatry; 2006 Nov; 19(6):631-6. PubMed ID: 17012944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.
    Stephen JH; Halpern CH; Barrios CJ; Balmuri U; Pisapia JM; Wolf JA; Kampman KM; Baltuch GH; Caplan AL; Stein SC
    Addiction; 2012 Mar; 107(3):624-34. PubMed ID: 21919988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription of heroin to treatment resistant heroin addicts: heroin handouts are flawed policy.
    Voth EA; Aeschbach E
    BMJ; 2004 Jan; 328(7433):229; author reply 229. PubMed ID: 14739208
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.
    Oviedo-Joekes E; Sordo L; Guh D; Marsh DC; Lock K; Brissette S; Anis AH; Schechter MT
    Addict Behav; 2015 Feb; 41():81-6. PubMed ID: 25452049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam.
    Vuong T; Shanahan M; Nguyen N; Le G; Ali R; Pham K; Vuong TTA; Dinh T; Ritter A
    Drug Alcohol Depend; 2016 Nov; 168():147-155. PubMed ID: 27664552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Craving and illicit heroin use among patients in heroin-assisted treatment.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial.
    Lintzeris N; Ritter A; Panjari M; Clark N; Kutin J; Bammer G
    Am J Addict; 2004; 13 Suppl 1():S29-41. PubMed ID: 15204674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002207. PubMed ID: 18425880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.